Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$227.28 +2.18 (+0.97%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Curent Deferred Tax Liability (2014 - 2015)

Updated

Analysis

Alnylam Pharmaceuticals (ALNY) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Alnylam Pharmaceuticals 30.17 Bn 18.22 Bn 992.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 9.41 Mn
Jun 30, 2015 19.65 Mn
Mar 31, 2015 33.67 Mn
Dec 31, 2014 31.67 Mn
API Access

Alnylam Pharmaceuticals Curent Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=ALNY&period=max&api_key=YOUR_API_KEY